" class="no-js "lang="en-US"> ProBioGen and ImmunOs Therapeutics to Deliver Cancer Therapy
Thursday, June 08, 2023

Breaking News

New “AI Doctor” Predicts Hospital Readmission and Other Health Outcomes Axol Bioscience Collaborates with StrataStem to Deliver Stem Cell-Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease MedTech Innovator Asia Pacific Names 24 Startups to Annual Accelerator XNK Therapeutics Appoints Hugo Petit as Chief Financial Officer Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas Therapeutics Abivax Appoints Ida Hatoum as Chief People Officer Eureka Therapeutics Awarded $10.6 Million CIRM Grant to Support Clinical Trial of ARTEMIS® T-Cell Therapy in Pediatric Liver Cancer Kallyope Appoints Franz Humer, Ph.D., as Chair of its Board of Directors BioCentriq® and Kytopen® Expand Partnership to Expedite Impact of Transformative Gene-Editing Technology on Cell Therapy Manufacturing FluoGuide Announces Positive Topline Results from Phase IIa Trial of FG001 in Lung Cancer
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients | MTA

April 13 2023

ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients

ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and ImmunOs Therapeutics announce the extension of their partnership for further large-scale manufacturing of clinical material for IOS-1002, ImmunOs’ lead program for the treatment of cancer. ProBioGen previously developed the cell line and the manufacturing process and provided the initial clinical material for ImmunOs’ innovative biologic.

“We highly appreciate the collaborative partnership with ProBioGen and the team’s dedication and solution orientation. The tireless effort of the ProBioGen team has enabled ImmunOs to start clinical development as planned and to meet our milestones,” said Jeff Abbey, Chief Operating Officer of ImmunOs Therapeutics.

“Partnership is one of our core values, as it is key in working successfully together. With this in mind we are confident that our continuous collaboration is based on mutual trust and reliability,” said Dr. René Brecht, Chief Operations Officer of ProBioGen.

  1. New “AI Doctor” Predicts Hospital Readmission and Other Health Outcomes

    News

     Read more
  2. Axol Bioscience Collaborates with StrataStem to Deliver Stem Cell-Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease

    Clinical Trials

     Read more
  3. MedTech Innovator Asia Pacific Names 24 Startups to Annual Accelerator

    News

     Read more
  4. XNK Therapeutics Appoints Hugo Petit as Chief Financial Officer

    Appointments

     Read more
  5. Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas Therapeutics

    Gene Therapy

     Read more
More On